JPH02291244A - Raw material for food or medicine and its production - Google Patents

Raw material for food or medicine and its production

Info

Publication number
JPH02291244A
JPH02291244A JP1303059A JP30305989A JPH02291244A JP H02291244 A JPH02291244 A JP H02291244A JP 1303059 A JP1303059 A JP 1303059A JP 30305989 A JP30305989 A JP 30305989A JP H02291244 A JPH02291244 A JP H02291244A
Authority
JP
Japan
Prior art keywords
chitosan
raw material
extracted
extract
dried
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1303059A
Other languages
Japanese (ja)
Other versions
JPH0466545B2 (en
Inventor
Yoshitaka Ikezuki
池月 義孝
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Deutz Yakuhin Kk
Original Assignee
Deutz Yakuhin Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutz Yakuhin Kk filed Critical Deutz Yakuhin Kk
Priority to JP1303059A priority Critical patent/JPH02291244A/en
Publication of JPH02291244A publication Critical patent/JPH02291244A/en
Publication of JPH0466545B2 publication Critical patent/JPH0466545B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PURPOSE:To obtain a raw material reduced in bitter taste, having excellent absorption-suppressing action of sugar in intenstinal tract, insoluble glucan production-inhibiting action, etc., and suitable for healthy food and medicine by adding and absorbing chitosan into extract of Gymnema Sylvestre. R. Br. CONSTITUTION:Dried leaf of Gymnema Sylvestre. R. Br. (hereinafter referred to as GS) is extracted with water or water-containing ethanol and the extracted liquid is concentrated and, as necessary, dried and pulverized. The chitosan obtained by deacetylating chitin contained in crab, lobster, etc., is added to the resultant extracted material and bitter taste ingredient of Gymnema Sylvestre. R. Br. extracted material is absorbed into chitosan to reduce bitter taste in the extent without hindrance on taste. Furthermore, amount of chitosan added is preferably about 100 to 700 pts.wt. based on 100 pts.wt. (expressed in terms of solid content) of GS extracted material. The resultant raw material composition is preferably used as a raw material for cake, bread, SOBA (buckwheat noodle), instant soap or other healthy food or various kind of medicines orally administered.

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は食品または医薬品原料およびその製造方法に関
し、詳しくは強烈な苦味を有するギムネマ・シルベスタ
抽出物に、キチンの脱アセチル化物であるキトサンを添
加することによって、強烈な苦味を低減または解消させ
た食品または医薬品原料およびその製造方法に関する。
[Detailed Description of the Invention] [Industrial Application Field] The present invention relates to a food or pharmaceutical raw material and a method for producing the same, and more specifically, chitosan, which is a deacetylated product of chitin, is added to Gymnema sylvestre extract, which has a strong bitter taste. The present invention relates to a food or pharmaceutical raw material whose intense bitterness is reduced or eliminated by the addition of the present invention, and a method for producing the same.

[従来の技術] インド原産の蔓性低木であるギムネマ・シルベスタ( 
G ynnema  S ylvestre, R .
  B r. ;以下1GSと略す)は、インド、中国
、東南アジア、アフリカ等の熱帯、亜熱帯地方に自生す
るカガイモ科に属する植物である。このGSはインドに
おいて、古来より糖尿病の民間療法として用いられ、一
般には乾燥した葉が多く利用され、食用されていた。こ
のGSは腸管における糖の吸収を抑制するため糖尿病に
効果を有するのみならず、甘味を抑制する効果や虫歯の
発生原因である砂糖の摂取により生ずる不溶性グルカン
の生成を阻害する作用のあることも確認されている。し
かし、これらの作用機構は明確でなかった。
[Conventional technology] Gymnema sylvestre (
Gynnema Sylvestre, R.
B r. ; hereinafter abbreviated as 1GS) is a plant belonging to the family Asclepiadaceae that grows naturally in tropical and subtropical regions such as India, China, Southeast Asia, and Africa. This GS has been used as a folk remedy for diabetes since ancient times in India, and the dried leaves were generally used and eaten. This GS not only has an effect on diabetes because it suppresses the absorption of sugar in the intestinal tract, but also has the effect of suppressing sweet taste and inhibiting the production of insoluble glucan caused by the intake of sugar, which is the cause of tooth decay. Confirmed. However, their mechanism of action was not clear.

近年、このGSの甘味抑制効果や腸管における糖の吸収
抑制効果等は、GSの有効成分であるギムネマ酸の特異
な生理作用によることが認められている。このギムネマ
酸はA1〜A4の同族体があり、その基本構造はトリテ
ルベンであるギムネマゲニン(3β,16β,21β,
22α, 23. 28−ヘキサヒドロキシオレアン−
12エン)の誘導体とDーグルクロン酸からなる配糖体
である。また、トリテルペンの水酸基は種々の有機酸で
エステル化されており、有機酸の種類はそれぞれ同族体
で異なっている。
In recent years, it has been recognized that the sweet taste suppressing effect of GS, the sugar absorption suppressing effect in the intestinal tract, etc. are due to the unique physiological action of gymnemic acid, which is an active ingredient of GS. This gymnemic acid has homologues A1 to A4, and its basic structure is gymnemagenin (3β, 16β, 21β,
22α, 23. 28-hexahydroxyoleane-
It is a glycoside consisting of a derivative of D-12ene) and D-glucuronic acid. Furthermore, the hydroxyl group of triterpenes is esterified with various organic acids, and the types of organic acids are different homologues.

GS乾燥葉は自生地で採取された後、一般には袋詰めに
よって流通されるが、不純物や夾雑物が混入したり、保
管時に品質が低下することが少なくない。また、土壌中
の微生物や細菌等に汚染されていることも多々ある。
After GS dried leaves are collected from their natural habitat, they are generally distributed in bags, but it is not uncommon for them to be contaminated with impurities or impurities, or for their quality to deteriorate during storage. In addition, soil is often contaminated with microorganisms and bacteria.

従って、GS乾燥葉をそのまま使用するのみならず、こ
れを加工する場合にも問題がある。
Therefore, there are problems not only when using GS dried leaves as they are, but also when processing them.

そこで、GS乾燥葉からギムネマ酸等を抽出して、得ら
れたGS抽出物を用いることが試みられている。GS抽
出物を得るには、水で抽出を行なったり、特開昭82−
248591号公報に記載されているような、含水アル
コールで抽出することが提案されている。GS乾燥葉を
含水アルコール等で抽出すると、ギムネマ酸とその同族
体化合物およびGS乾燥葉中に含まれるタンニン、有機
酸、クロロフィル等を含む抽出液が得られる。さらに、
これを乾燥すると淡黄緑色の粉末が得られる。
Therefore, attempts have been made to extract gymnemic acid and the like from dried GS leaves and use the resulting GS extract. To obtain the GS extract, extract with water or
It has been proposed to extract with hydrous alcohol as described in Japanese Patent No. 248591. When GS dried leaves are extracted with hydrous alcohol or the like, an extract containing gymnemic acid and its homologs, tannins, organic acids, chlorophyll, etc. contained in the GS dried leaves is obtained. moreover,
When this is dried, a pale yellow-green powder is obtained.

[発明が解決しようとする課題] しかしながら、GS乾燥葉を水または含水エタノールで
抽出したGS抽出物は、2〜3myを服用しても苛烈な
苦味があり、味覚に異常を生じ砂糖の甘味を全く感じな
くなり、この現象は数十分持続する。この現象は舌の表
面にある甘味を感じる味覚機能のみを麻痺させるためと
言われている。
[Problems to be Solved by the Invention] However, the GS extract obtained by extracting dried GS leaves with water or aqueous ethanol has a strong bitter taste even when taken at a dose of 2 to 3 my, causing an abnormality in taste and making it difficult to taste the sweetness of sugar. You won't feel it at all, and this phenomenon will last for several minutes. This phenomenon is said to be due to the paralysis of only the gustatory function on the surface of the tongue that detects sweetness.

このことはGS抽出物を食品に添加し加工する場合や医
薬品の用途に用いる場合に望ましくない現象であり、食
品や医薬品の製造、特に食品の分野において、GS抽出
物の利用を望む要請が多大であるにも拘わらず利用でき
ない原因となっている。
This is an undesirable phenomenon when GS extracts are added to food for processing or used for pharmaceutical purposes, and there are many requests for the use of GS extracts in food and pharmaceutical manufacturing, especially in the food field. However, this is the reason why it cannot be used.

このようなGS抽出物の苦味を解消する方法として、特
開昭84−2552号公報にはGS抽出物に澱粉を添加
する方法が提案されているが、GS抽出物の苦味を充分
に実用的な水準まで解消する有効な方法とは言い難かっ
た。また、GS抽出物を特定の無機物に吸着する方法も
あるが、この方法は苦味の改良には一定限度良好な効果
が認められたが、無機物を食品に添加する場合には規制
があり、無機物の使用やその使用量が制限されるという
難点を有する。
As a method to eliminate such bitterness of GS extract, Japanese Patent Application Laid-Open No. 84-2552 proposes a method of adding starch to GS extract. It was difficult to say that it was an effective method to eliminate the problem to such a high level. There is also a method of adsorbing GS extracts to specific inorganic substances, but this method has been shown to be effective to a certain extent in improving bitterness, but there are regulations when adding inorganic substances to food, and inorganic substances The disadvantage is that the use of and the amount of use thereof is limited.

従って、上述のようにGS抽出物が食品や医薬品原料と
して有望であるにも拘らず、その苦味から実用化される
に至っていないのが現状である。
Therefore, as mentioned above, although GS extracts are promising as raw materials for foods and medicines, the present situation is that they have not been put into practical use due to their bitter taste.

本発明は、上記課題を解決すべくなされたもので、GS
抽出物の苦味を実用的水準までに低減または解消し、か
つ副作用が生じたり、GS抽出物の有する効果を損うこ
とのない食品または医薬品原料およびその製造方法を提
供することを目的とする。
The present invention has been made to solve the above problems, and
The purpose of the present invention is to provide a food or pharmaceutical raw material that reduces or eliminates the bitterness of the extract to a practical level and does not cause side effects or impair the effects of the GS extract, and a method for producing the same.

[課題を解決するための手段] 本発明者は、上記目的に沿って種々検討を行なった結果
、GS乾燥葉の抽出液を濃縮したGS抽出物に、キチン
を脱アセチル化して得られるキトサンを添加することに
より、苦味が無いか或いは使用上支障ない程度に苦味を
軽減し得ることを知見し、本発明に至った。
[Means for Solving the Problems] As a result of various studies in line with the above objectives, the present inventor added chitosan obtained by deacetylating chitin to a GS extract obtained by concentrating an extract of dried GS leaves. The present inventors have discovered that, by adding these compounds, the bitterness can be reduced to such an extent that there is no bitterness or there is no problem in use, and the present invention has been achieved.

すなわち本発明は、ギムネマ・シルベスタ(GS)抽出
物とキトサンを含有することを特徴とする食品または医
薬品原料にある。
That is, the present invention resides in a food or pharmaceutical raw material characterized by containing a Gymnema sylvestre (GS) extract and chitosan.

本発明でいうGS抽出物とは、GS乾燥葉を水または含
水エタノールで抽出し、得られたギムネマ酸等を含有す
る抽出液を濃縮した抽出濃縮液、またはこれを乾燥して
粉体化した抽出粉末をいう。
The GS extract referred to in the present invention refers to an extracted concentrate obtained by extracting dried GS leaves with water or aqueous ethanol and concentrating the resulting extract containing gymnemic acid, etc., or a concentrated extract obtained by drying and powdering this. Refers to extracted powder.

このようなGS抽出物を抽出する方法として特開昭82
−248591号公報に記載の方法が例示される。
As a method for extracting such GS extract, Japanese Patent Application Laid-open No. 82
The method described in Japanese Patent No. 248591 is exemplified.

具体的な抽出方法は、例えば異物を選別したGS乾燥葉
を秤量した後水洗し、50%程度のエタノールで3回を
目安として抽出し、抽出液から常法によりエタノールを
回収した後、濃縮して抽出濃縮液を得るか、もしくはこ
の抽出濃縮液を乾燥または噴霧乾燥により抽出粉末とす
る。この乾燥には低温加熱乾燥やスプレードライ法等が
好ましく採用される。
A specific extraction method is, for example, after weighing the dried GS leaves from which foreign substances have been removed, they are washed with water, extracted with approximately 50% ethanol three times, and after recovering ethanol from the extract using a conventional method, they are concentrated. Alternatively, the extracted concentrate is dried or spray-dried to obtain an extracted powder. For this drying, low temperature heating drying, spray drying, etc. are preferably employed.

上記の操作により得られる抽出物の量は、原料が天然物
のため、収穫時期、生育場所によって収量が異なる。一
般には、抽出液に50%アルコールを使用した場合には
、GS乾燥葉100重量部に対してGS抽出物(固〜形
分)が25〜35重量部、抽出液に温湯を使用した場合
には、GS乾燥葉100重量部に対してGS抽出物(固
形分)が17〜23重量部得られる。
Since the raw material is a natural product, the yield of the extract obtained by the above operation varies depending on the harvest time and growing location. In general, when 50% alcohol is used for the extract, the GS extract (solid to solid content) is 25 to 35 parts by weight per 100 parts by weight of dried GS leaves, and when hot water is used for the extract. yields 17 to 23 parts by weight of GS extract (solid content) per 100 parts by weight of dried GS leaves.

本発明では、このGS抽出物にキトサンを添加、吸着さ
せる。
In the present invention, chitosan is added and adsorbed to this GS extract.

キトサンは天然の高分子物質でカニ、エビ等の外殻その
他に含まれるキチン(ポリーN−アセチルーβ一D−グ
ルコサミン)を脱アセチル化して得られるポリーβ一D
−グルコサミンで、天然物として存在し、生体構成成分
として食用にも供せられ、吸収性手術用縫合糸の原料等
にも検討されるように安全性が極めて高いものである。
Chitosan is a natural polymeric substance obtained by deacetylating chitin (poly N-acetyl-β-D-glucosamine) found in the outer shells of crabs, shrimps, etc.
- Glucosamine exists as a natural product, is edible as a biological component, and is extremely safe, as it is being considered as a raw material for absorbable surgical sutures.

また生体内分解性であるため消化管内で吸着したGS抽
出物内のギムネマ酸を放出することができる。キトサン
は工業的にも水処理凝集剤として高分子物質の捕集や重
金属の吸着等にも大量に使用されており、また酸溶液中
ではアンモニウム塩を形成し、天然物でカチオン性を示
す特異な性質を有する物質である。このキトサンを添加
することにより、GS抽出物の苦味成分を効率良く吸着
し、味覚上支障ない程度に苦味を軽減する。
Furthermore, since it is biodegradable, it can release gymnemic acid in the GS extract adsorbed in the gastrointestinal tract. Chitosan is used in large quantities industrially as a water treatment flocculant to collect polymeric substances and adsorb heavy metals. It also forms ammonium salts in acid solutions and is a unique natural product that exhibits cationic properties. It is a substance that has certain properties. By adding this chitosan, the bitter components of the GS extract are efficiently adsorbed, and the bitterness is reduced to an extent that does not affect the taste.

本発明に用いられるキトサンの脱アセチル化度は特に制
限されず、好ましくは平均で80〜90%、特に望まし
くは85〜90%のものが良い。
The degree of deacetylation of chitosan used in the present invention is not particularly limited, and is preferably 80 to 90% on average, particularly preferably 85 to 90%.

このキトサンを添加する具体的な方法は、市販のキトサ
ンを5%程度の酢酸等の稀酸によって溶解して粘性の液
体として、これにGS抽出濃縮液または抽出粉末を加え
て充分に混練した後に乾燥する。稀酸の濃度は必ずしも
5%程度でなくてもよく、混合物が軟らかいときは10
%またはそれ以上の濃度の酢酸を用いても良い。
The specific method of adding this chitosan is to dissolve commercially available chitosan in dilute acid such as about 5% acetic acid to form a viscous liquid, add GS extraction concentrate or extracted powder to this, and thoroughly knead it. dry. The concentration of dilute acid does not necessarily have to be around 5%, but if the mixture is soft, it can be as high as 10%.
% or higher concentration of acetic acid may be used.

このGS抽出濃縮液または抽出粉末と吸着すべきキトサ
ンの配合割合は、GS抽出物(固形分)100重量部に
対してキトサンは望ましくは 100〜700重量部、
さらに望ましくは500〜700重量部が苦味の軽減効
果と使用上の容量から適当である。
The blending ratio of the GS extraction concentrate or extracted powder and the chitosan to be adsorbed is preferably 100 to 700 parts by weight of chitosan per 100 parts by weight of the GS extract (solid content).
More preferably, 500 to 700 parts by weight is appropriate from the viewpoint of reducing bitterness and usage capacity.

キトサンが100重量部未満では苦味の軽減効果が少な
く、他方700重量部を超えると経済性や容量が増大す
るといった問題が生じる。
If the amount of chitosan is less than 100 parts by weight, the effect of reducing bitterness will be small, while if it exceeds 700 parts by weight, problems such as increased economy and capacity will occur.

このようにして本発明の食品または医薬品原料が得られ
るが、この原料には本発明の効果を損なわない範囲で還
元剤等の各種添加剤を含有させることができる。
In this way, the food or pharmaceutical raw material of the present invention is obtained, and this raw material can contain various additives such as a reducing agent within a range that does not impair the effects of the present invention.

本発明の原料は、食品原料、例えば和菓子、洋菓子等の
菓子類;パン類;蕎麦麺、スパゲッティ等の加工穀物類
;即席スープ、即席シチュー ジュース類、或いはその
他の健康食品等の原料として好適に用いられるほか、経
口投与される各種薬剤の原料としても使用可能である。
The raw material of the present invention is suitable as a food raw material, such as confectionery such as Japanese sweets and Western confectionery; bread; processed grains such as soba noodles and spaghetti; instant soup, instant stew, juice, or other health foods. In addition to being used, it can also be used as a raw material for various drugs that are administered orally.

[発明の効果] ギムネマ・シルベスタ(GS)抽出物とキトサンを含有
する本発明の食品または医薬品原料は、苦味が実用上充
分な程度までに低減され、しかもキトサンは安全性が高
く、生体内分解性であるため、ギムネマ・シルベスタが
本来有している腸管における糖の吸収抑制、甘味抑制、
あるいは虫歯の発生の原因である砂糖の摂取により生ず
る不溶性グルカンの生成阻害といった効能を充分に発揮
させることができる。
[Effect of the invention] The food or pharmaceutical raw material of the present invention containing Gymnema sylvestre (GS) extract and chitosan has bitterness reduced to a practically sufficient level, and chitosan is highly safe and biodegradable. Due to its nature, Gymnema sylvestre naturally inhibits sugar absorption in the intestinal tract, suppresses sweet taste,
Alternatively, it is possible to fully exhibit the effect of inhibiting the production of insoluble glucan caused by the intake of sugar, which is the cause of dental caries.

従って、本発明は食品、特に健康食品の添加剤等に使用
されるのみならず、医薬品またはその添加剤としての用
途も期待される。
Therefore, the present invention is expected to be used not only as an additive for foods, especially health foods, but also as an additive for pharmaceuticals and their additives.

[実施例] 以下、実施例および実験例に基づいて本発明を具体的に
説明する。
[Examples] The present invention will be specifically described below based on Examples and Experimental Examples.

実施例I GS乾燥葉logを50%エタノール100dで3回抽
出し、濾液を蒸発乾燥して2.6gのGS抽出粉末を得
た。
Example I GS dried leaf log was extracted three times with 100 d of 50% ethanol, and the filtrate was evaporated to dryness to obtain 2.6 g of GS extracted powder.

これにキトサン(TNキトサン:脱アセチル化度90%
、日本理化学薬品■)25gを加え均一な色調になるま
で混練した。更に混練しなから 526酢酸を徐々に加
えると次第に粘性を示した。この時pHは約4.0であ
った。
To this, chitosan (TN chitosan: degree of deacetylation 90%
, Nippon Rikagaku Yakuhin ■) was added and kneaded until a uniform color tone was obtained. When 526 acetic acid was gradually added without further kneading, the mixture gradually became viscous. At this time, the pH was about 4.0.

この混合物を40〜50℃で乾燥したのち粉砕、濾過し
て目的の原料粉末を得た。この粉末は日中を通過する間
に殆ど苦味を感じなかった。
This mixture was dried at 40 to 50°C, then ground and filtered to obtain the desired raw material powder. The powder had almost no bitter taste during the day.

実施例2 実施例1と同様にして得た抽出濾液を濃縮して約10d
とし、これにキトサン30gを加え均一になるまで混合
した。これに5%酢酸を徐々に加え充分混練して粘性の
ある泥状物を得た。このときのpHは約4.0であった
。これに炭酸水素ナトリウムを粉末のまま少量均一に添
加しながら混練すると、次第に粘性を失ない混練器の器
壁に付着しなくなった。なお、炭酸水素ナトリウムを加
える量はpH  8.5〜7.0になる点で終了した。
Example 2 The extracted filtrate obtained in the same manner as in Example 1 was concentrated to about 10 d
30 g of chitosan was added to this and mixed until uniform. 5% acetic acid was gradually added to the mixture and thoroughly kneaded to obtain a viscous slurry. The pH at this time was about 4.0. When a small amount of sodium hydrogen carbonate was uniformly added as a powder while kneading the mixture, the mixture gradually lost its viscosity and no longer adhered to the wall of the kneader. Note that the amount of sodium hydrogen carbonate added was stopped when the pH reached 8.5 to 7.0.

この混合物を薄く広げ40〜45℃で乾燥した。このと
きに乾燥温度が高いと表面が褐色化するので真空乾燥で
行なった。乾燥後粉砕して得られた粉末は全く苦味は感
じなかった。
This mixture was spread thinly and dried at 40-45°C. At this time, if the drying temperature was high, the surface would turn brown, so vacuum drying was performed. The powder obtained by grinding after drying did not taste bitter at all.

実験例1 実施例1で得られた粉末原料をマウスに投与し、急性毒
性試験を行なった。マウスは5週齢の雄ICRマウスを
用い、常法により飼育し、7日間の馴化後、健康を確か
めて実験に供した。上記粉末原料を2,5g秤量してメ
スシリンダーに入れ、196 C M Cを含む生理食
塩水を加え全量20IIdlとし、L25m9/rdの
液を作成し被検液とした。
Experimental Example 1 The powdered raw material obtained in Example 1 was administered to mice, and an acute toxicity test was conducted. The mice used were 5-week-old male ICR mice, which were bred in a conventional manner, and after 7 days of acclimatization, their health was confirmed and used for the experiment. 2.5 g of the above powdered raw material was weighed and put into a measuring cylinder, and physiological saline containing 196 CM C was added to make a total volume of 20 II dl to prepare a solution of L25 m9/rd, which was used as a test solution.

被検液の投与は、ステンレス製金属ゾンデによる 1回
の強制経口投与とした。投与容積は4 2 0 0 1
119/ KFI ノ場合let lmj! / 30
 g体重とし、2100m97Kgの場合は0.5m/
30gとした。
The test solution was administered once by forced oral administration using a stainless steel metal probe. Administration volume is 4 2 0 0 1
119/ In case of KFI let lmj! / 30
g weight, if 2100m97Kg, 0.5m/
It was set to 30g.

症状の観察期間は投与後7日間とし、死亡の有無および
マウスの一般症状について、投与日は投与1時間後まで
連続的に、その後30分毎に投与4時間まで観察し、翌
日から哄1日 2回午前と午後に観察した。このマウス
の死亡率を第1表に示した。
The observation period for symptoms was 7 days after administration, and the presence or absence of death and general symptoms of the mice were observed continuously on the day of administration until 1 hour after administration, then every 30 minutes until 4 hours after administration, and from the next day onwards for 1 day. Observations were made twice, once in the morning and once in the afternoon. The mortality rate of these mice is shown in Table 1.

体重測定は投与直前および投与後はl、2、4、6日後
に行ない、その体重変化を第2表に示した。
Body weight was measured immediately before administration and 1, 2, 4, and 6 days after administration, and the changes in body weight are shown in Table 2.

この結果、第1表に示されるように4200m’j/K
9の投与で死亡は認められず、LD5.値は4200f
fig/Kg以上であった。また、第2表に示されるよ
うに、体重変化はいずれの投与群でも体重増加は認めら
れなかった。一般症状も投与直後から一般状態の以上は
認められず、剖検所見の結果も肉眼検査では異常は認め
られなかった。
As a result, as shown in Table 1, 4200 m'j/K
No death was observed after administration of LD5.9. The value is 4200f
It was more than fig/Kg. Furthermore, as shown in Table 2, no increase in body weight was observed in any of the administration groups. No general symptoms were observed immediately after administration, and no abnormalities were observed in the autopsy findings by visual inspection.

このことから、本発明の粉末原料のマウスの経口投与に
よる急性毒性は極めて弱いものであり、その安全性が確
認された。
From this, the acute toxicity of the powdered raw material of the present invention when administered orally to mice was extremely weak, and its safety was confirmed.

第 表 実験例2 実施例1で得られた粉末原料を、アイスクリーム原料、
チョコレート原料、バン原料、スパゲッティ原料、即席
スープ原料中に添加し、それぞれアイスクリーム、チョ
コレート、バン、スパゲッティ、即席スープを製造した
Table 2 Experimental Example 2 The powder raw material obtained in Example 1 was used as an ice cream raw material,
It was added to chocolate raw materials, bun raw materials, spaghetti raw materials, and instant soup raw materials to produce ice cream, chocolate, buns, spaghetti, and instant soup, respectively.

これらのものを食用に供したところ、いずれも苦み等の
違和感はなく、本来各食品の有する食味が味わえた。
When these foods were eaten, there was no unpleasant taste such as bitterness, and the original flavor of each food could be enjoyed.

特許出願人 ドイツ薬品株式会社 代理人 弁理士 伊 東 辰 雄 代理人 弁理士 伊 東 哲 也Patent applicant: Deutsche Yakuhin Co., Ltd. Agent: Patent Attorney Tatsuo Ito Agent: Patent Attorney Tetsuya Ito

Claims (1)

【特許請求の範囲】 1、ギムネマ・シルベスタ抽出物とキトサンを含有する
ことを特徴とする食品または医薬品原料。 2、ギムネマ・シルベスタ抽出物にキトサンを添加、吸
着させることを特徴とする食品または医薬品原料の製造
方法。
[Claims] 1. A food or pharmaceutical raw material characterized by containing a Gymnema sylvestre extract and chitosan. 2. A method for producing a food or pharmaceutical raw material, which comprises adding and adsorbing chitosan to a Gymnema sylvestre extract.
JP1303059A 1989-02-27 1989-11-24 Raw material for food or medicine and its production Granted JPH02291244A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1303059A JPH02291244A (en) 1989-02-27 1989-11-24 Raw material for food or medicine and its production

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP4322489 1989-02-27
JP1-43224 1989-02-27
JP1303059A JPH02291244A (en) 1989-02-27 1989-11-24 Raw material for food or medicine and its production

Publications (2)

Publication Number Publication Date
JPH02291244A true JPH02291244A (en) 1990-12-03
JPH0466545B2 JPH0466545B2 (en) 1992-10-23

Family

ID=26382973

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1303059A Granted JPH02291244A (en) 1989-02-27 1989-11-24 Raw material for food or medicine and its production

Country Status (1)

Country Link
JP (1) JPH02291244A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6438026A (en) * 1987-07-31 1989-02-08 Nitto Denko Corp Glucide absorption inhibitor

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6438026A (en) * 1987-07-31 1989-02-08 Nitto Denko Corp Glucide absorption inhibitor

Also Published As

Publication number Publication date
JPH0466545B2 (en) 1992-10-23

Similar Documents

Publication Publication Date Title
JP3018013B2 (en) α-amylase activity inhibitor
EP2517711B1 (en) Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and foods and beverages
JPH09291039A (en) Antiobestic medicine comprising procyanidin as active ingredient
JP5997856B2 (en) Method for producing oral composition
WO2010013551A1 (en) Preparation for oral administration comprising water-extracted chondroitin sulfate and quercetin glycoside
JP2005170837A (en) Marine alga extract and saccharide hydrolase inhibitor containing the same
JP3261090B2 (en) Antidiabetic agent and food containing it
JP4499209B2 (en) Obesity prevention and improvement agent
JP2006104181A (en) Glucide-splitting enzyme-inhibiting material derived from fagaceae plant and application thereof
EP1283048B1 (en) Therapeutic agent for improving bladder function or treating urinary disturbance and food and drink containing it
JP3130327B2 (en) Liver dysfunction preventive agent and functional food having hepatic dysfunction preventive action
WO2005094858A1 (en) Antidiabetic composition
KR102487651B1 (en) A composition for preventing, improving or treating sarcopenia comprising extracts of wheat sprout
JPH02291244A (en) Raw material for food or medicine and its production
JPH0940572A (en) Inhibitor of amylase and composition for inhibiting amylase
JP3203572B2 (en) Method for improving palatability of pine extract and oral intake obtained by this method
AU2003220049A1 (en) Dispersed solid-containing complex carbohydrate
JP4982648B2 (en) Metal deposition inhibitor
JP2005022994A (en) Hypoglycemic composition
CN110710672A (en) Natural plant active calcium preparation and preparation method thereof
JPH08133970A (en) Blood sugar increase inhibitor and its use
US20230021051A1 (en) Composition Containing Black Ginger Extract and Composition for Oral Administration
KR100679698B1 (en) An extract of Pterocarya paliurus with blood sugar level-lowering activity and functional food comprising the same
JP5008813B2 (en) Anti-Skin Cancer Agent Containing Cubileta Extract
JP2006306769A (en) Apoptosis inducing agent, food and drink and medicine containing the same, and method for producing the apoptosis inducing agent